Brian Corvese Mi Nk Therapeutics, Inc. (INKT) insider trading activity

Brian Corvese is of MiNK Therapeutics, Inc.. Currently has a direct ownership of 48,441 shares of INKT, which is worth approximately $680,111. The most recent transaction as insider was on Sep 02, 2025, when has been sold 1,290 shares (Common Stock) at a price of $13.86 per share, resulting in proceeds of $17,879. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.4K

2.74% 3M change

88.05% 12M change

Total Value Held $680,111

Brian Corvese Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2025	BUY Grant, award, or other acquisition	$17,879 $13.86 p/Share	1,290 Added 2.59%	48,441 Common Stock
Jun 02 2025	BUY Grant, award, or other acquisition	$17,881 $7.17 p/Share	2,494 Added 5.02%	47,151 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	$17,870 $8.79 p/Share	2,033 Added 4.35%	44,657 Common Stock
Dec 01 2024	BUY Grant, award, or other acquisition	$17,812 $0.73 p/Share	24,400 Added 5.41%	426,283 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	$17,877 $0.82 p/Share	21,802 Added 5.1%	405,296 Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	$17,787 $0.99 p/Share	17,967 Added 4.48%	383,494 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	$17,875 $0.95 p/Share	18,816 Added 4.9%	365,527 Common Stock
Dec 01 2023	BUY Grant, award, or other acquisition	$17,875 $1.04 p/Share	17,188 Added 4.72%	346,711 Common Stock
Sep 01 2023	BUY Grant, award, or other acquisition	$17,876 $1.46 p/Share	12,244 Added 3.58%	329,523 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	$17,876 $1.76 p/Share	10,157 Added 3.1%	317,505 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	$17,875 $2.09 p/Share	8,553 Added 2.71%	307,348 Common Stock
Dec 01 2022	BUY Grant, award, or other acquisition	$17,875 $2.61 p/Share	6,849 Added 2.24%	298,795 Common Stock
Sep 15 2022	BUY Grant, award, or other acquisition	$35,753 $2.62 p/Share	13,646 Added 50.0%	13,646 Common Stock

Also insider at

AGEN

AGENUS INC Healthcare

PTIXW

Protagenic Therapeutics, Inc.new ETFs

Director

Brian Corvese

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Value

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to MiNK Therapeutics, Inc.

Track Activities on INKT

Account